Evaluating the health impact, health-system costs and cost-effectiveness of using TrueNat on stool samples compared to usual care for the diagnosis of paediatric tuberculosis in primary care settings: A modelling analysis.

Evaluating the health impact, health-system costs and cost-effectiveness of using TrueNat on stool samples compared to usual care for the diagnosis of paediatric tuberculosis in primary care settings: A modelling analysis.

Show other versions (1)

The World Health Organisation (WHO) recommends rapid molecular diagnostics to improve bacteriological confirmation of tuberculosis in children. TrueNat MTB, MTB Plus and MTB-RIF Dx assays (Molbio Diagnostics, India), recommended by WHO, hold potential as point-of-care tests in resource-limited setti...

Full description

Saved in:
Bibliographic Details
Main Authors: Nyashadzaishe Mafirakureva, Olugbenga Kayode Daniel, Olabamiji Jamiu Olayinka, Kingsley Chinedum Ochei, Eveline Klinkenberg, Austin Ihesie, Debby Nongo, Rupert Amanze Eneogu, Andwele Mwansasu, Emeka Uga Elom, Agbaje Vivian Aderonke, Patrick Sunday Dakum, Charles Olalekan Mensah, Oluwafemi Christopher Odola, Abiola Oladotun Olayemi, Emily Yemisi Faleye, Adekunle Omotoso Makinde, Peter J Dodd
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0004016
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items